BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Teneligliptin
1
Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies
11/18/2024 3:30:39 AM | Browse: 114 | Download: 543
2
Potential mechanism of teneligliptin in the treatment of diabetic cardiomyopathy
9/26/2024 8:51:01 AM | Browse: 141 | Download: 761
3
Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy?
8/27/2024 3:11:19 PM | Browse: 140 | Download: 705
4
Teneligliptin: A potential therapeutic approach for diabetic cardiomyopathy
7/26/2024 6:56:09 AM | Browse: 186 | Download: 755
5
Diabetic cardiomyopathy: Emerging therapeutic options
7/26/2024 6:56:09 AM | Browse: 179 | Download: 554
6
Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome
4/12/2024 1:04:39 AM | Browse: 143 | Download: 1262
7
Drug interactions of dipeptidyl peptidase 4 inhibitors involving CYP enzymes and P-gp efflux pump
4/30/2019 3:02:03 AM | Browse: 1151 | Download: 1707
8
Dipeptidyl peptidase-4: A key player in chronic liver disease
9/16/2014 1:19:00 PM | Browse: 1570 | Download: 1662
Write to the Help Desk
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345